Search

everythinglearnresearchcommunity

for

Search:↓

Men with severe hair loss may have a higher risk of heart disease.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Consider benefits and risks of new alopecia treatments for safety.

Hair growth and health are influenced by stress and hormones.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Higher CRBP1 levels are linked to more severe alopecia areata.

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Certain herbal combinations in traditional Chinese medicine might be effective for treating hair loss, focusing on liver or stomach health.

A single amino acid change in the vitamin D receptor can disrupt its function and lead to hair loss.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.